DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

MannKind Corp (NASDAQ: MNKD)

4.80 -0.16 (-3.23%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MNKD $4.80 -3.23%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.97
Previous Close $4.96
Daily Range $4.76 - $4.97
52-Week Range $4.45 - $11.48
Market Cap $2.0B
P/E Ratio -9.73
Dividend (Yield) $0.00 (0.0%)
Volume 6,150,894
Average Daily Volume 3,427,029
Current FY EPS -$0.34

Sector

Healthcare

Industry

Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary Rss Feed

10 Most Hated Companies in Healthcare

When emotional trading is on display, the short-sellers come out to play. Find out which companies are the most hated in healthcare, why they're so universally disliked, and which company may eventually deserve a reprieve.

MannKind Corporation: A Good Risk/Reward Play For The Long Haul

Marketocracy Top 20 Manager, Nate Pile, Invested In MannKind And Afrezza

3 Questions to Ask Before You Buy a Biotech Stock

One Motley Fool analyst explains the key questions investors should answer before buying biotech stocks.

Pain-Free Blood Tests? Sign Me Up!

A small, Wisconsin-based company could be on the verge of developing a revolutionary new blood test that is virtually pain-free. Find out how personalized healthcare is transforming the medical field.

8 Analyst Stocks Under $10 With Massive Upside Calls

What's Afrezza's Ultimate Potential For MannKind?

Colorectal cancer biotech Xbiotech prices $76 million IPO at $19 midpoint

Short Sellers Increase Their Bets Against Biotech Stocks

Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind

See More MNKD News...

MNKD's Top Competitors

MNKD $4.80 (-3.23%)
Current stock: MNKD
AMGN $167.91 (-0.74%)
Current stock: AMGN
BIIB $401.71 (-6.64%)
Current stock: BIIB
CELG $118.71 (2.26%)
Current stock: CELG